Logo image of 1SHL.MI

SIEMENS HEALTHINEERS AG (1SHL.MI) Stock Fundamental Analysis

BIT:1SHL - Euronext Milan - DE000SHL1006 - Common Stock - Currency: EUR

43.65  -2.75 (-5.93%)

Fundamental Rating

5

1SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. While 1SHL is still in line with the averages on profitability rating, there are concerns on its financial health. 1SHL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1SHL had positive earnings in the past year.
In the past year 1SHL had a positive cash flow from operations.
In the past 5 years 1SHL has always been profitable.
Each year in the past 5 years 1SHL had a positive operating cash flow.
1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCF1SHL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

1SHL's Return On Assets of 4.11% is fine compared to the rest of the industry. 1SHL outperforms 68.97% of its industry peers.
1SHL has a better Return On Equity (10.04%) than 77.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.21%, 1SHL is in the better half of the industry, outperforming 70.69% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1SHL is below the industry average of 8.46%.
The 3 year average ROIC (5.87%) for 1SHL is below the current ROIC(6.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.11%
ROE 10.04%
ROIC 6.21%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1SHL.MI Yearly ROA, ROE, ROIC1SHL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

1SHL has a better Profit Margin (8.76%) than 65.52% of its industry peers.
In the last couple of years the Profit Margin of 1SHL has declined.
1SHL's Operating Margin of 12.85% is fine compared to the rest of the industry. 1SHL outperforms 68.97% of its industry peers.
In the last couple of years the Operating Margin of 1SHL has declined.
1SHL has a worse Gross Margin (38.18%) than 70.69% of its industry peers.
1SHL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.85%
PM (TTM) 8.76%
GM 38.18%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
1SHL.MI Yearly Profit, Operating, Gross Margins1SHL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

1SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
1SHL has more shares outstanding than it did 1 year ago.
1SHL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1SHL has an improved debt to assets ratio.
1SHL.MI Yearly Shares Outstanding1SHL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SHL.MI Yearly Total Debt VS Total Assets1SHL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

1SHL has an Altman-Z score of 1.86. This is not the best score and indicates that 1SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
1SHL has a Altman-Z score (1.86) which is in line with its industry peers.
1SHL has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as 1SHL would need 6.15 years to pay back of all of its debts.
1SHL has a better Debt to FCF ratio (6.15) than 67.24% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that 1SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, 1SHL is doing worse than 70.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 6.15
Altman-Z 1.86
ROIC/WACC1.09
WACC5.71%
1SHL.MI Yearly LT Debt VS Equity VS FCF1SHL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1SHL has a Current Ratio of 1.28. This is a normal value and indicates that 1SHL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1SHL (1.28) is comparable to the rest of the industry.
A Quick Ratio of 0.89 indicates that 1SHL may have some problems paying its short term obligations.
1SHL has a Quick ratio (0.89) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.89
1SHL.MI Yearly Current Assets VS Current Liabilites1SHL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.84% over the past year.
Measured over the past 5 years, 1SHL shows a small growth in Earnings Per Share. The EPS has been growing by 7.27% on average per year.
The Revenue has been growing slightly by 4.09% in the past year.
1SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)10.84%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%4.08%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%5.91%

3.2 Future

1SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.77% yearly.
The Revenue is expected to grow by 5.26% on average over the next years.
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.77%
Revenue Next Year5.94%
Revenue Next 2Y6.14%
Revenue Next 3Y6.36%
Revenue Next 5Y5.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1SHL.MI Yearly Revenue VS Estimates1SHL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
1SHL.MI Yearly EPS VS Estimates1SHL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.40, the valuation of 1SHL can be described as rather expensive.
1SHL's Price/Earnings ratio is a bit cheaper when compared to the industry. 1SHL is cheaper than 75.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 24.85, 1SHL is valued a bit cheaper.
1SHL is valuated correctly with a Price/Forward Earnings ratio of 15.30.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SHL indicates a somewhat cheap valuation: 1SHL is cheaper than 68.97% of the companies listed in the same industry.
1SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.89.
Industry RankSector Rank
PE 19.4
Fwd PE 15.3
1SHL.MI Price Earnings VS Forward Price Earnings1SHL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1SHL is valued a bit cheaper than the industry average as 74.14% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 1SHL is valued cheaply inside the industry as 89.66% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.22
EV/EBITDA 15.09
1SHL.MI Per share data1SHL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1SHL has a very decent profitability rating, which may justify a higher PE ratio.
1SHL's earnings are expected to grow with 12.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)2.67
EPS Next 2Y13.11%
EPS Next 3Y12.78%

6

5. Dividend

5.1 Amount

1SHL has a Yearly Dividend Yield of 2.13%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.53, 1SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, 1SHL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

On average, the dividend of 1SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

1SHL pays out 53.55% of its income as dividend. This is a bit on the high side, but may be sustainable.
1SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP53.55%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
1SHL.MI Yearly Income VS Free CF VS Dividend1SHL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1SHL.MI Dividend Payout.1SHL.MI Dividend Payout, showing the Payout Ratio.1SHL.MI Dividend Payout.PayoutRetained Earnings

SIEMENS HEALTHINEERS AG

BIT:1SHL (4/10/2025, 7:00:00 PM)

43.65

-2.75 (-5.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners10.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.24B
Analysts82.96
Price Target64.4 (47.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP53.55%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.98%
Min EPS beat(2)3.67%
Max EPS beat(2)8.28%
EPS beat(4)3
Avg EPS beat(4)4.22%
Min EPS beat(4)-0.13%
Max EPS beat(4)8.28%
EPS beat(8)5
Avg EPS beat(8)2.12%
EPS beat(12)8
Avg EPS beat(12)2.61%
EPS beat(16)10
Avg EPS beat(16)3.31%
Revenue beat(2)1
Avg Revenue beat(2)0.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.15%
Revenue beat(16)8
Avg Revenue beat(16)0.73%
PT rev (1m)0.63%
PT rev (3m)8.03%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-3.95%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.72%
Valuation
Industry RankSector Rank
PE 19.4
Fwd PE 15.3
P/S 2.17
P/FCF 18.22
P/OCF 14.33
P/B 2.49
P/tB N/A
EV/EBITDA 15.09
EPS(TTM)2.25
EY5.15%
EPS(NY)2.85
Fwd EY6.54%
FCF(TTM)2.4
FCFY5.49%
OCF(TTM)3.05
OCFY6.98%
SpS20.1
BVpS17.53
TBVpS-5.4
PEG (NY)1.59
PEG (5Y)2.67
Profitability
Industry RankSector Rank
ROA 4.11%
ROE 10.04%
ROCE 7.92%
ROIC 6.21%
ROICexc 6.76%
ROICexgc 28.88%
OM 12.85%
PM (TTM) 8.76%
GM 38.18%
FCFM 11.92%
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 6.15
Debt/EBITDA 3.39
Cap/Depr 59.34%
Cap/Sales 3.24%
Interest Coverage 8.67
Cash Conversion 82.8%
Profit Quality 136.12%
Current Ratio 1.28
Quick Ratio 0.89
Altman-Z 1.86
F-Score6
WACC5.71%
ROIC/WACC1.09
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)10.84%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%4.08%
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.77%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%5.91%
Revenue Next Year5.94%
Revenue Next 2Y6.14%
Revenue Next 3Y6.36%
Revenue Next 5Y5.26%
EBIT growth 1Y31.99%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year53.67%
EBIT Next 3Y23.22%
EBIT Next 5Y15.57%
FCF growth 1Y165.16%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y80.08%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%